問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
蔡尚峰
下載
2021-11-01 - 2026-02-28
Condition/Disease
Test Drug
Participate Sites5Sites
Recruiting5Sites
2022-01-05 - 2029-11-11
Participate Sites9Sites
Recruiting9Sites
2025-09-30 - 2029-12-31
xxxxxx
Participate Sites4Sites
Recruiting4Sites
2024-03-15 - 2031-12-31
Immunoglobulin A Nephropathy (IgAN)
injection
Participate Sites10Sites
Not yet recruiting1Sites
2025-08-01 - 2028-12-31
Participate Sites3Sites
Recruiting3Sites
2025-02-15 - 2028-12-31
2021-09-21 - 2026-06-01
2025-11-01 - 2030-12-31
Participate Sites6Sites
Recruiting6Sites
2024-12-30 - 2031-06-30
Kidney Transplantation
TRK-001
2022-05-02 - 2026-09-30
Sibeprenlimab (VIS649) Sibeprenlimab (VIS649)
全部
